Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration has approved Foundation Medicine's FoundationFocus CDxBRCA, the first next-generation sequencing-based companion diagnostic on the market.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.